Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-26 @ 2:24 AM
Study NCT ID:
NCT05571059
Status:
RECRUITING
Last Update Posted:
2025-09-24
First Post:
2022-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor:
Cumberland Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-27
First Submit QC Date:
None
Study First Post Date:
2022-10-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED